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Background: Persistent symptoms of reﬂux esophagitis (RE) trigger two choices in management:
repeating endoscopy and prolonging proton pump inhibitor (PPI) treatment. The main purpose of this
study was to evaluate the clinical outcomes between the two approaches in older patients with mild RE.
Methods: Data of a retrospective cohort from 6702 endoscopies done in a tertiary medical center in
Taiwan were obtained. In total, 1059 patients (mean age¼ 52.9 16.7 years, 56.0% men) with ﬁrst-ever
endoscopic diagnosis of mild RE (Los Angeles Grade A/B) were enrolled. The medical records of patients’
progress over the next 12 months were then reviewed.
Results: Overall, 199 patients received either repeated endoscopies or prolonged PPI treatment because of
the presence of symptoms. Among them, 140 (13.2%) patients (mean age¼ 57.9 15.6 years, 62.9% men)
had repeated endoscopies and 59 (5.6%) patients (mean age¼ 64.7 15.6, 71.2% men) received pro-
longed PPI treatment, indicating that physicians tended to favor repeated endoscopies rather than persist
with PPI use in Taiwan. Multivariate logistic regression showed that age >60 years [odds ratio (OR)¼
2.89, 95% conﬁdence interval (CI)¼ 1.65e5.05, p< 0.001]; presence of Barrett’s esophagus (OR¼ 4.07,
95% CI¼ 1.53e10.79, p¼ 0.005); and presence of hiatal hernia (OR¼ 2.55, 95% CI¼ 1.25e5.21, p¼ 0.01)
were all independent predictive factors for persistent PPI use.
Conclusion: Among older patients with mild RE, physicians tended to repeat endoscopies than prolong
PPI treatment when presence of dyspepsia was noted but no malignancy had been identiﬁed. A practice
guideline on the treatment of mild RE in older patients would be helpful for physicians to guide their
management of such patients.
Copyright  2011, Asia Paciﬁc League of Clinical Gerontology & Geriatrics. Published by Elsevier Taiwan
Open access under CC BY-NC-ND license.LLC.1. Introduction
The prevalence of reﬂux esophagitis (RE) increases with age.1
Although prevalence rates vary from country to country,2 most
studies in recent years have shown a common rising trend in the
prevalence of this disease.1 In fact, RE has replaced peptic ulcer
disease to be the leading cause of dyspepsia in many countries.1
Epidemiological studies in Taiwan have shown that the preva-
lence of RE signiﬁcantly increased from the 1970s to
the 1990s.3e5 A previous study indicated that 5.0e14.5% ofGerontology, Taipei Veterans
aipei 112, Taiwan, R.O.C.
n).
linical Gerontology & Geriatrics. Psymptomatic people receiving upper gastrointestinal endoscopy
were diagnosed with RE,6 with most of these being mild in
clinical grading.7 Compared with younger patients, older patients
with RE tend to have more severe disease on endoscopic grading
and are more likely to have hiatal hernia.8 As a result, the
treatment response in older patients with RE may be different
from that in younger patients.
Although older age is considered an important risk factor for RE,
little is known regarding the treatment outcomes of RE in older
patients. Despite the increased incidence of RE in older patients, no
evidence-based practice guidelines are available in the manage-
ment of mild RE in this group of patients. The purpose of this study
was to evaluate the treatment approaches to mild RE in older
patients and to examine the outcomes and endoscopic ﬁndings of
those who have alarm symptoms, with the aim of improving clin-
ical care of mild RE in older people.ublished by Elsevier Taiwan LLC. Open access under CC BY-NC-ND license.
Table 1
Comparisons between patients with mild reﬂux esophagitis receiving repeated
endoscopy or not
Endoscopy repeated
(N¼ 140)
Endoscopy not
repeated (N¼ 919)
p
Age (y) 57.9 15.6 52.6 17.0 0.001
Male (%) 62.9 55.5 0.102
Barrett’s esophagus (%) 2.1 3.3 0.345
Hiatal hernia (%) 9.3 7.0 0.324
PPI treatment (%) 71.4 64.3 0.099
Persistent PPI treatment (%) 10.0 4.9 0.014
Asymptomatic patients (%)a 17.1 16.3 0.807
a Asymptomatic patients refer to those whose primary endoscopic examination
was performed during a health checkup.
PPI¼ proton pump inhibitor.
Table 2
Factors predictive of persistent proton pump inhibitor use in patients with mild
reﬂux esophagitis
Factors Odds ratio 95% Conﬁdence interval p
Hiatal hernia 2.55 1.25e5.21 0.01
Age> 60 y 2.89 1.65e5.05 <0.001
Barrett’s esophagus 4.07 1.53e10.79 0.005
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2.1. Study participants
All reports of upper gastrointestinal endoscopies done in Tai-
chung Veterans General Hospital from July to December, 2006,
were retrieved, and patients with a newly established endoscopic
diagnosis of mild RE (Los Angeles Grade A/B)9 were enrolled in the
study. Demographic data, endoscopic diagnosis, and the treatment
prescribed for each patient were recorded in detail. Patients with
endoscopic evidence of active peptic ulcer disease, radiation or
candida esophagitis, previous esophageal or gastric surgery, any
malignancy of the upper gastrointestinal tract, or those scheduled
for endoscopic treatment or follow-up were excluded. The medical
records of all study participants were subsequently retrieved, and
each patient’s progress after enrollment till December 2007 was
reviewed.
2.2. Endoscopic diagnosis
Macroscopic severity of the RE was determined by the gastro-
enterologist, and RE was endoscopically deﬁned by mucosal breaks
according to the Los Angeles classiﬁcation.9 Hiatal hernia was
diagnosed when the Z line and the gastric folds extended 2 cm or
more above the diaphragmatic hiatus. Barrett’s esophagus was
diagnosed based on endoscopic ﬁndings.
2.3. Pharmacological treatment and repeated endoscopies
All patients in the study were treated with proton pump inhib-
itor (PPI) unless they could not tolerate the medication. Currently,
the National Health Insurance Program in Taiwan recommends
4 consecutive months of PPI treatment for patients with mild RE,
regardless of age. However, the need for extended PPI treat-
mentdthat is, longer than 4months in durationdcan be decided by
the physician, based on clinical assessment of the patient’s symp-
toms. In general, physicians would either persist with PPI treatment
or repeat the endoscopy if the 4-month PPI course did not fully
relieve the patient’s symptoms. This is especially relevant for
patients who have alarm symptoms. In this study, alarm symptoms
were deﬁned as advancing age, history of weight loss, recurrent
vomiting, dysphagia, evidence of bleeding or anemia, or a failed
response to empirical treatment.10 Persistent PPI treatment was
deﬁned as PPI prescribed for >80% of the time to sustain the
remission of symptoms.11,12 The decision whether to prolong PPI
treatment or repeat the endoscopy was recorded for each patient.
2.4. Statistical analysis
All continuous variables were expressed as mean standard
deviation. Comparisons between categorical data were performed
using the Chi-square test or Fisher’s exact test, and continuous
variables were compared using the Student t test. Multiple logistic
regression was used to determine the independent risk factors for
persistent PPI use and repeated endoscopies. Receiver operation
curve was used to determine the best cutoff of age in logistic
regression. All statistical analyses were performed using commer-
cial statistical software (SPSS version 16.0; SPSS Inc., Chicago, IL,
USA). For all tests, a p value <0.05 (two-tailed) was considered
statistically signiﬁcant.
3. Results
In total, 6702 endoscopic reports were retrieved and 1852
patients were found to have endoscopically conﬁrmed RE. Afterexcluding 793 patients with severe RE (Los Angeles Grade C/D),
data of 1059 patients with mild RE (mean age¼ 52.916.7 years,
56.0% men) were retrieved, and their medical records for the next
12 months were reviewed.
In the study period, 199 (18.8%) patients remained symptomatic
after the initial PPI treatment course and received either repeated
endoscopic examinations or prolonged PPI treatment. Among them,
repeated endoscopic examinations were performed for 140 (13.2%)
patients, with a mean interval of 9.3 4.2 months after the ﬁrst
endoscopy. Compared with those who did not have repeated endo-
scopic examinations, patients who had repeated endoscopies were
signiﬁcantly older (57.915.6 years vs. 52.617.0 years, p< 0.001)
and more likely to receive persistent PPI treatment (10.0% vs. 4.9%,
p¼ 0.014) (Table 1). Among the patients who underwent repeated
endoscopies, subsequent endoscopic ﬁndings revealed that 29.3%
were RE free,10.7% had progressed to develop severe RE (Los Angeles
Grade C/D), 50.7% remained with mild RE, and the remaining 9.3%
had other benign diagnoses.Multiple logistic regression showed that
age >60 years was the only independent risk factor for repeated
endoscopic examinations [odds ratio (OR)¼ 1.90, 95% conﬁdence
interval (CI)¼ 1.32e2.73, p< 0.001].
In contrast, 59 (5.6%) patients of the studycohortwere prescribed
continued PPI treatment (mean treatment duration¼ 13.9 2.2
months) without repeating endoscopy. Compared with those who
needed no more than 4 months of PPI treatment, patients who
required persistent PPI treatment weremore likely to bemale, older,
and have concomitant Barrett’s esophagus or hiatal hernia (Table 2).
Moreover, multiple logistic regression showed that age >60 years
(OR¼ 2.89, 95% CI¼ 1.65e5.05, p< 0.001); presence of Barrett’s
esophagus (OR¼ 4.07, 95%CI¼ 1.53e10.79, p¼ 0.005); andpresence
of hiatal hernia (OR¼ 2.55, 95% CI¼ 1.25e5.21, p¼ 0.01) were all
independent predictive factors for persistent PPI use (Table 2).
However, whether patientswere symptomatic (those recruited from
outpatient departments) or asymptomatic (those diagnosed on
health checkups) did not signiﬁcantly affect the need for persistent
PPI use (21.4% vs. 18.3%, p¼ 0.33).
4. Discussion
Despite the increased prevalence of RE in older people, the
optimum treatment approach for these patients remained unclear.
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Program recommends 4 consecutivemonths of PPI treatment for all
patients with mild RE. In this study, only 5.6% of patients needed
more than 4months of PPI treatment, whereas 13.2% of the patients
underwent repeated endoscopic examinations. The results also
indicated that 18.8% (199 out of 1059 patients who had repeated
endoscopies or prolonged PPI treatment) of older patients with
mild RE were not completely free of symptoms after 4 consecutive
months of PPI treatment. Based on our study ﬁndings, it would
seem that gastroenterologists prefer to repeat endoscopic exami-
nations rather than persist with PPI treatment. This may be
explained by the fact that physicians tend to adhere strictly to
national practice guidelines, and the increased risk of gastric
malignancy in older patients might be a “motivating” factor for
physicians to repeat the endoscopies. However, in our study, no
malignant lesions were detected in the repeated endoscopies. A
recent study also noted that the rate of malignancy detected from
gastroscopies performed in people older than 85 years with sound
indications was low (3.8%).13 In another more recent study, it was
mentioned that older patients with RE are more likely to receive
gastroscopic examinations because (1) they may lack the typical
symptoms of RE (heartburn and acid regurgitation) and (2) older
patients tend to present with alarm symptoms (anorexia, weight
loss, anemia, vomiting, and/or dysphagia).14 An earlier study clearly
demonstrated, however, that neither age nor the presence of alarm
symptoms correlates well with endoscopic ﬁndings.15 Therefore,
the practice of performing gastroscopy for older people with
dyspepsia or other alarm symptoms deserves further consideration.
In this study, we found that being male, age >60 years, having
Barrett’s esophagus, andhiatalherniawereall signiﬁcantlyassociated
with persistent PPI use. These ﬁndings are compatible with those of
a previous long-term observational cohort study in Taiwan, which
revealed that the presence of hiatal hernia and the severity of
esophagitis at initial endoscopy were predictive of the requirement
for long-term acid suppression therapy.16 Older agewas also noted in
the same study to be an important factor contributing to the need for
long-termPPI treatment.16 Thismay be explained by the frequencyof
comorbidities present in older patients, a greater need for come-
dications, more frequent physician visits,11 a higher incidence of
hiatal hernia, andmore severeREon clinical grading.8 Physiologically,
decreased salivary ﬂow, decreased gastric acid production, decreased
esophageal motility, slowed gastric emptying, and decreased lower-
esophageal tone in older people may increase gastroesophageal
reﬂux, imposing the need for a longer period of PPI treatment.
From the repeated gastroscopic examinations in this study, we
found that 10.7% of patients had progressed to develop more severe
RE. A previous study reported that the prevalence of severity
progression in follow-up endoscopies was 10.5%,17 a ﬁgure which is
similar to that observed in our study. Nevertheless, only 28.3% of
patients were endoscopically cured and 66.4% of those who had
repeated endoscopies remained with mild RE. Several risk factors
predicting the progression of severity have been reported, including
older age, female sex, the presence of hiatal hernia, the presence of
symptoms at the time of initial diagnosis, the absence of atrophy of
the stomach endoscopically, the absence of Helicobacter pylori
infection, and poor esophageal motility.17 Further investigation may
be needed in this respect to determine the predictive factors for RE
severity progression in older Taiwanese individuals.
Although we reviewed a large number of endoscopic reports
and medical records, there were several limitations in this study.
First, a comprehensive survey of the patients’ upper gastrointes-
tinal symptoms was lacking because it was a retrospective obser-
vational study. However, because physicians often base their
treatment decisions on the patient’s symptoms, whether the
patient received persistent PPI treatment or had a repeatedendoscopic examinations was probably closely related to his or her
symptoms. Therefore, the treatment given to each patient can be
considered appropriate even though the investigators were not
able to conduct a symptom review during the study. Second, there
is always the possibility of patients buying over-the-counter acid-
suppression agents, and this was not recorded in the National
Health Insurance Program in Taiwan. However, because all patients
were insured under the National Health Insurance Program, we
believe that the vast majority of patients requiring long-term PPI
treatment would seek proper medical attention instead of buying
over-the-counter acid-suppression agents. Third, an overestimation
of persistent PPI use was likely because we analyzed prescriptions
based on medical records, not through conducting personal inter-
views with the patients. Therefore, patients may not have been fully
compliant with their medication on becoming asymptomatic.
Despite the aforementioned limitations, the strength of this study
was that all patients had a reliable endoscopic diagnosis of RE, and
patients with other pathologies were excluded. Because of cost and
reimbursement issues regarding PPI prescription in Taiwan, most of
the patients in this study were completely followed even though it
was a retrospective observational study.
In conclusion, 18.8% of older patients with mild RE may persist
symptomatic after 4 consecutive months of PPI treatment. Among
patients with persistent or alarm symptoms, physicians tended
to repeat endoscopies, but 86.8% of them had not progressed in
severity, and no malignant lesions were identiﬁed. Further study
regarding the necessity of repeated endoscopic examinations in
older patients with mild RE would be helpful for establishing some
clinical guidelines regarding the management of such patients.
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